EdgeMarket › What Bain Capital Life Sciences Investors, Llc reported owning
What Bain Capital Life Sciences Investors, Llc reported owning
As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
1.1BPositions
20Quarter
2026-03-31Shown below
20largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| HTFL Heartflow, Inc. | 254.2M | 22.9% | 10.4M | 49.75 | +69.7% |
| NAMS NewAmsterdam Pharma Co N.V. | 233.9M | 21.1% | 7.3M | 27.87 | +14.6% |
| OLMA Olema Pharmaceuticals, Inc. | 111.4M | 10.0% | 7.5M | 10.69 | +96.1% |
| SVRA Savara Inc | 96.1M | 8.7% | 17.6M | 5.59 | +80.9% |
| PHVS Pharvaris N.V. | 75.6M | 6.8% | 2.7M | 36.27 | +57.7% |
| SLDB Solid Biosciences Inc. | 70.6M | 6.4% | 9.8M | 9.30 | +64.3% |
| XFOR X4 Pharmaceuticals, Inc | 32.9M | 3.0% | 8.0M | 4.04 | +44.3% |
| DNTH Dianthus Therapeutics, Inc. /DE/ | 30.4M | 2.7% | 362.5K | 111.10 | +374.4% |
| ANNX Annexon, Inc. | 28.9M | 2.6% | 5.2M | 5.07 | +136.9% |
| KYTX Kyverna Therapeutics, Inc. | 26.8M | 2.4% | 3.1M | 8.42 | +145.5% |
| CABA Cabaletta Bio, Inc. | 26.0M | 2.3% | 9.7M | 3.13 | +98.1% |
| unmapped CUSIP 152309100 | 25.2M | 2.3% | 635.0K | — | — |
| ALKS Alkermes plc. | 21.6M | 1.9% | 610.0K | 48.33 | +66.8% |
| RPID RAPID MICRO BIOSYSTEMS, INC. | 19.1M | 1.7% | 8.4M | 1.68 | -32.5% |
| CCCC C4 Therapeutics, Inc. | 18.9M | 1.7% | 7.2M | 4.00 | +53.8% |
| AVIR Atea Pharmaceuticals, Inc. | 12.7M | 1.1% | 2.4M | 5.43 | +55.1% |
| IRON Disc Medicine, Inc. | 9.0M | 0.8% | 141.2K | 79.81 | +35.9% |
| UPB Upstream Bio, Inc. | 7.8M | 0.7% | 867.2K | 6.97 | -57.4% |
| XLO Xilio Therapeutics, Inc. | 5.6M | 0.5% | 664.0K | 9.23 | -0.6% |
| unmapped CUSIP N62509117 | 2.0M | 0.2% | 100.0K | — | — |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →